Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
969 13 |
Ultima descărcare din IBN: 2024-03-28 23:29 |
SM ISO690:2012 BUTOROV, Serghei, GONCIAR, Veaceslav, BUTOROV, Ivan, CONDARUC, Natalia. Eficacitatea clinică a citoprotectorului miocardic Trimetazidina MB în tratamentul pacienţilor cu bronhopneumopatie cronică obstructivă, complicată cu cord pulmonar cronic. In: Curierul Medical, 2012, nr. 4(328), pp. 3-6. ISSN 1875-0666. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Curierul Medical | ||||||
Numărul 4(328) / 2012 / ISSN 1875-0666 | ||||||
|
||||||
Pag. 3-6 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
The conducted research included 55 patients with severe and moderate degrees of chronic obstructive pulmonary disease (COPD), treated with cytoprotector – trimetazidine in combination with basic therapy. During the investigation, it was determined that including a dose of 35 mg of trimetazidine (Preductal MB, “Servier” France) twice a day into the complex therapy of patients with severe and moderate degrees of COPD, provided a faster regression of clinical symptoms, reducing lung hypertension and decreasing morphofunctional heart changes. |
||||||
Cuvinte-cheie COPD, chronic pulmonary heart, trimetazidine |
||||||
|